Tuesday, 29 Jul 2025
  • About Us
  • Contact Us
  • Privacy Policy
  • Terms & Conditions
  • DMCA
Subscribe
Brinks Report
  • Featured
  • Money Matters
  • Business
  • IPL
  • Technology
  • Automobile
  • Entertainment
  • Sports
  • More
    • People
    • World
    • Health and Wellness
    • Horoscope
  • Today’s News
  • 🔥
  • World
  • Business
  • Economy
  • Technology
  • Automobile
  • Entertainment
  • People
  • India
  • Sports
  • IPL
Font ResizerAa
Brinks ReportBrinks Report
Search
  • Featured
  • Money Matters
  • Business
  • IPL
  • Technology
  • Automobile
  • Entertainment
  • Sports
  • More
    • People
    • World
    • Health and Wellness
    • Horoscope
  • Today’s News
Have an existing account? Sign In
Follow US
© 2024-2025 Brinks Report. All content, including text, images, and other media, is copyrighted.
Brinks Report > Blog > Business > Morepen Labs Expands Overseas with New Entity in Dubai Free Zone
Business

Morepen Labs Expands Overseas with New Entity in Dubai Free Zone

Dolon Mondal
Last updated: June 19, 2025 10:55 am
Dolon Mondal
Share
Morepen labs
SHARE
Trulli

Morepen Labs isn’t slowing down. In a bold move to scale its global game, the Indian pharmaceutical giant has launched a wholly owned subsidiary in Dubai — Morepen Labs FZCO.

This new venture will focus on trading medicines and pharmaceutical products, outside the UAE, marking a strategic shift to deepen its international footprint. Morepen Labs subscribed to 5,000 ordinary shares of AED 10 each, totaling AED 50,000. With this, the company signals that it’s not just playing local anymore. It’s aiming higher.

Trulli

Why Dubai? Because it’s the ultimate global hub — perfect for reaching Europe, Africa, and Asia from one place. And Morepen wants in.

A Company With Global Grit

Morepen Labs is no newbie in the pharma world. It’s a vertically integrated, innovation-first company that creates APIs, branded generics, medical devices, and wellness products. Right now, they serve over 80 countries — and Dubai just unlocked more doors.

The new setup is also a related party, as it’s 100% owned by the parent company. That keeps control tight, and vision tighter.

Also Read Despite 133% Profit Jump, Inventurus Drops as 10 Cr Shares Hit Market

Behind the Headlines: A Tough Quarter

Even bold moves come with challenges. In Q4 FY25, Morepen’s net profit dropped 28.18% to Rs 20.31 crore. That’s despite a 10.11% jump in revenue, which hit Rs 465.85 crore. So yes, the company is still growing — but it’s navigating some bumps.

Markets noticed. The Morepen Labs stock fell 2.29% to Rs 62.23 on the BSE. But if this Dubai deal delivers, sentiment could flip fast.

What This Means Going Forward

Morepen Labs isn’t waiting for luck. It’s building scale, one region at a time. By setting up base in Dubai, it’s chasing smoother exports, better trade routes, and stronger business connections.

If you’re following India’s rise in pharma, this is a story to watch. This move speaks volumes — about ambition, strategy, and intent. And Morepen’s not hiding any of it.

From here, it’s about execution. Will Dubai become Morepen’s global launchpad? Time will tell. But one thing’s clear — they’re not here to play small.

Also Read Tata Tech Secures Volvo Deal as ‘Strategic Supplier’; Stock Rebounds After 6-Day Drop

Image Slider
Image 1 Image 2 Image 3
TAGGED:Dubai subsidiaryMorepen Labs
Share This Article
Facebook Whatsapp Whatsapp Copy Link Print
What do you think?
Love0
Sad0
Happy0
Joy0
Sleepy0
Angry0
Surprise0
Previous Article Tata technologies Tata Tech Secures Volvo Deal as ‘Strategic Supplier’; Stock Rebounds After 6-Day Drop
Next Article Tesla Showdown in Texas: Democratic Lawmakers Try to Block Tesla’s Robotaxi Rollout!
Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Your Trusted Source for Accurate and Timely Updates!

Brink’s Report delivers fresh, unbiased, and engaging content across politics, business, tech, entertainment, and more. From breaking news to deep dives, we keep you informed—and intrigued—with accurate reporting and diverse perspectives. Explore the world, one story at a time.
FacebookLike
XFollow
RSS FeedFollow
Ad image

You Might Also Like

Alembic pharma
Business

Alembic Pharma Shares Jump 10.92% After USFDA Approval for Cancer Drug

By
Dolon Mondal
Mahindra
Business

How Mahindra’s ₹42,599 Crore Sales Surge Is Changing India’s Auto Landscape

By
Dolon Mondal
Mamaearth q4 fy25: revenue up 13%, net profit dips
BusinessEconomy

Honasa Consumer Shares Rise 16% After Q4 FY25 Results; Revenue Grows 13% Year-on-Year to ₹534 Crore

By
Ankita Das
Copy of image 2025 07 08t103706. 215
Business

Adani Power Buys Vidarbha Plant for ₹4,000 Crore, Adds 2,300 MW Capacity

By
Dolon Mondal
Ad image

About US


Brink’s Report delivers fresh, unbiased, and engaging content across politics, business, tech, entertainment, and more. From breaking news to deep dives, we keep you informed—and intrigued—with accurate reporting and diverse perspectives. Explore the world, one story at a time.

Top Categories
  • World
  • Business
  • Economy
  • Technology
Usefull Links
  • Contact Us
  • About Us
  • Privacy Policy
  • DMCA

© 2024-2025 Brinks Report. All content, including text, images, and other media, is copyrighted.